CBD News

Multistate cannabis operator Curaleaf will pay $100,000 to settle a class-action lawsuit related to a 2021 incident wherein the company sold drops labeled for CBD but which actually contained THC.

The MLB announced an official partnership with the CBD company Charlotte’s Web in a first-of-its-kind deal for the major national sports league.

The FTC is issuing product refunds for customers who bought CBD products from Kushly Industries LLC after the company made unsubstantiated treatment claims regarding CBD’s effects on ailments ranging from acne to cancer.

The U.S. House Agriculture Committee held a hearing last week to discuss the state of the hemp industry and how the government can continue to support the crop.

The National Basketball Association Players Association has entered a multi-year partnership for branded CBD products with Harrington Wellness, a CBD brand founded by former player Al Harrington.

The MLB will begin to allow CBD product sponsorships as long as the products do not have active levels of THC.

A special report by Project CBD details the chemistry of cannabinoids and how a concept called chirality enables the synthetic production of new cannabinoids like Delta-8 THC; the report also highlights the risk of potentially unleashing new, “hidden dangers” in the process.

The Portland attorney who previously settled 10 lawsuits against Curaleaf for its THC/CBD product mix-up is now seeking $200 per customer regardless of whether they were made ill by the products.

The majority of CBD products marketed for sleep are inaccurately labeled for CBD, CBN, or melatonin content, according to a recent study by Leafreport.

George Harrison’s 1970 album ‘All Things Must Pass’ will be honored in a new CBD/CBG product line from Dad Grass, with the promise of a “pleasant-but-manageable buzz.”

The U.S. Trademark Trial and Appeal Board declined to register a hemp CBD company’s trademark, citing the federal prohibition of CBD and saying the product meets the definition of a drug but has not been approved by the FDA.

A recent poll found that less than half of U.S. parents know much about the use of CBD products with regard to children and most have never tried CBD themselves.

The NFL is donating $1 million to researchers to study the effects of cannabinoids on pain management in elite athletes.

A new report found a 5,100% price difference between the most expensive and most affordable CBD consumer products.

Tennessee lawmakers are set to consider multiple pieces of cannabis reform legislation this year, including a bill to tax delta-8 THC and CBD products, as well as broader medical and adult-use cannabis bills.

The Constitutional Council of France ruled that CBD is not addictive or harmful, overturning a ban on the possession, use, and sale of CBD put in place in December.

Many advocates and patients cite cannabis as a powerful sleep aid, but what does the recent research say?

The biotech pharma firm ANANDA Scientific Inc. announced it has received FDA approval to study a CBD-based drug as a treatment for opioid-use disorder.

Curaleaf has settled 10 lawsuits related to its mix-up last year of THC and CBD tinctures at a Portland, Oregon facility. Additional cases, including a wrongful death suit, are still pending.